Definitive Contract HHSD200201688808C

Award Date 3/29/16
Potential Completion Date 3/28/17
Potential Value $1.1M
Federal Agency
CDC Pittsburgh
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Potomac, MD 20850, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract was awarded by the Department of Health and Human Services Centers for Disease Control and Prevention to Fisher Bioservices Inc., a subsidiary of Thermo Electron Corporation. The $2,799,087.88 contract is for biorepository services, including the storage, maintenance, and distribution of biological specimens, cell lines, vaccines, drugs, and medical devices to support biomedical research and public health initiatives. The contract is a definitive contract with a time and...
This is a $2,420,689.94 definitive contract awarded by the Centers for Disease Control and Prevention (CDC) to Fisher Bioservices Inc., a subsidiary of Thermo Electron Corporation. The contract is for biorepository services to support the National Center on Birth Defects and Developmental Disabilities (NCBDDD) projects, including the National Birth Defects Prevention Study and Division of Blood Disorders projects. The contract has a 60-month period of performance and involves the transfer,...
This is a federal contract awarded by the National Institutes of Health (NIH) to Fisher Bioservices Inc., a subsidiary of Thermo Electron Corporation. The $88,088,558.96 contract is for biomedical research support services, including storage, maintenance, distribution, and other repository services for biological specimens, cell lines, vaccines, drugs, and medical devices. The contract is a Definitive Contract with a Cost Plus Fixed Fee pricing type and has no set-aside designation. Fisher...
This is a $40,769,874.54 cost-plus-fixed-fee contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the U.S. Department of Health and Human Services, to Fisher Bioservices Inc. Clinical Trials Division, a subsidiary of Thermo Electron Corporation. The contract has no set-aside designation. The contract supports a variety of biomedical research and public health initiatives, including the management and distribution of biological specimens, cell...
This is a definitive contract awarded by the Department of Health and Human Services National Institutes of Health National Cancer Institute to Fisher Bioservices Inc., a division of Thermo Electron Corporation, for the storage and distribution of clinical agents. The contract has a potential value of $29,398,963.86 and is a cost plus fixed fee arrangement. The contract does not have a set-aside designation. As a prime contractor, Fisher Bioservices provides a variety of goods and services to...
This is a $226,259.86 delivery order awarded by the Department of Health and Human Services Office of the Assistant Secretary for Administration to Fisher Bioservices Inc., a division of Thermo Electron Corporation. The contract is a Firm Fixed Price order placed under the Multiple Award Schedule (MAS) contract vehicle. The work to be performed includes storage, maintenance, distribution, and other repository services for biological specimens, cell lines, vaccines, drugs, and medical devices...
This is a firm fixed-price purchase order contract awarded by the Department of Health and Human Services' National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases to Fisher Bioservices, Inc. for $17,209.92. The contract provides testing laboratory and storage services and has a completion date of March 31, 2025. Fisher Bioservices is a for-profit organization that specializes in the management of critical biological materials to support advanced therapies,...
This is a firm fixed-price purchase order contract awarded by the Defense Health Agency to Fisher Bioservices Inc., a subsidiary of Thermo Electron Corporation, to provide biorepository support services. The $4,231,616.95 contract has an ultimate completion date of January 31, 2024. The original solicitation was posted as a special notice with no set-aside designation, indicating Fisher Bioservices competed as an unrestricted contractor. The contract work encompasses a range of biorepository...
This federal contract award, valued at $149,777.24, was made by the National Cancer Institute (NCI) to Fisher Bioservices Inc., a subsidiary of Thermo Electron Corporation. The contract is for off-site storage of refrigerated, cryopreserved, and frozen biological materials. This delivery order contract is part of the Scientific Equipment and Services (FSS-66) schedule under the General Services Administration (GSA). The contract does not have a set-aside designation. Fisher Bioservices is an...
This federal contract award to Fisher Bioservices Inc. Clinical Trials Division, a subsidiary of Thermo Electron Corporation, is for the provision of repository services to support the National Institute of Allergy and Infectious Diseases (NIAID). The $13,247.06 firm fixed-price purchase order contract involves the storage, maintenance, distribution, and other repository services for biological specimens, cell lines, vaccines, drugs, and medical devices. Fisher Bioservices has extensive...

This is a $1,095,917.99 firm fixed-price definitive contract awarded by the Centers for Disease Control and Prevention (CDC) to Fisher Bioservices Inc., a subsidiary of Thermo Electron Corporation. The contract is for the provision of bio-repository and inventory management services, including the storage, maintenance, distribution, and other repository services for biological specimens, cell lines, vaccines, drugs, and medical devices.

Fisher Bioservices has extensive experience as both a prime contractor and subcontractor on federal contracts and grants supporting biomedical research and public health initiatives for agencies such as the National Institutes of Health (NIH), CDC, and Department of Defense (DoD). The contract does not have a set-aside designation, reflecting Fisher Bioservices' established position in the field. The contract is not associated with a larger indefinite delivery vehicle (IDV), but Fisher Bioservices does hold two significant IDVs with the National Cancer Institute and the National Institute of Allergy and Infectious Diseases for providing comprehensive support for critical stages of drug discovery and development within major federal research programs.

Generated 4/2/25, 8:03 PM